Variant Summary
- Also known as
- GLY12ARG,RS121913530
- HGVS
- NM_004985.4:c.34G>C,NP_004976.2:p.Gly12Arg,NC_000012.11:g.25398285C>G,ENST00000256078.4:c.34G>C
- Variant Type(s)
- missense_variant
- Evidence Items
- 5
Evidence Level Distribution
Level B: 1Level C: 2Level D: 2
Evidence Items
Showing CIViC evidence rows where gene = KRAS and variant = G12R.
| Level | Type | Direction | Significance | Disease | Drugs | Rating |
|---|---|---|---|---|---|---|
| B | Prognostic | Supports | Poor Outcome | Pancreatic Cancer | 4 | |
| D | Predictive | Supports | Resistance | Colorectal Cancer | Cetuximab | 4 |
| C | Predictive | Supports | Resistance | Colorectal Cancer | Chemotherapy,Cetuximab | 3 |
| D | Predictive | Supports | Resistance | Colorectal Cancer | Regorafenib Anhydrous | 1 |
| C | Predictive | Supports | Resistance | Colorectal Cancer | Panitumumab | 0 |